| J9271 | Injection, pembrolizumab, 1 mg | 12,000 | $40 | $480.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,240 | $40 | $123.2K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,650 | $20 | $36.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 240 | $110 | $25.1K |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 2,190 | $10 | $21.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $130 | $8.7K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 20 | $210 | $4K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 70 | $50 | $3.8K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 290 | $10 | $3.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 60 | $60 | $3.6K |